Home
About
Technology
Pipeline
Investors
News
Contact

News

Newsletter | June 2017

27 Jun 2017

Patrys is pleased to share its latest Newsletter, published June 2017. Key highlights: Letter from our CEO Update on deoxymabs…

Previous 1 … 7 8 9 10

Patrys Limited

Patrys is a publicly-listed company company focused on developing novel antibody technologies for hard-to-treat cancers.

Newsletter

Get news and updates from Patrys delivered to your inbox.

Stay Connected

Keep up to date with the latest news from Patrys by following us on social media.

© 2021 Patrys Limited. All rights reserved.

ASX
Privacy Policy

Menu